Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine and sufentanil dose-finding for sedation during endoscopic ultrasonography
ChiCTR1800019273Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and sufentanil in gastrointestinal conditions, sponsored by Beijing Friendship Hospital. Primary endpoints: respiratory depression and Observer's Assessment of Alertness/Sedation Scale. Started Nov 2018; status: recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR1800019273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019273.